ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,354.03
1.18%
Dow Jones
38,807.33
0.25%
US Dollar vs MXN
17.46492
-0.31%
Brent Oil
78.505
-0.07%
Bitcoin
71,069.71
-0.01%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Arno Therapeutics Inc (CE) (ARNI)

  7. Arno Therapeutics Inc (CE) (ARNI) Noticias

ARNI

Arno Therapeutics (CE) (ARNI)

Arno Therapeutics Inc (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:ARNI
FechaHoraFuenteTítuloSímboloCompañía
03/01/201816:21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARNIArno Therapeutics Inc (CE)
03/04/201705:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARNIArno Therapeutics Inc (CE)
28/03/201716:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ARNIArno Therapeutics Inc (CE)
28/03/201716:00Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ARNIArno Therapeutics Inc (CE)
09/01/201711:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ARNIArno Therapeutics Inc (CE)
09/01/201711:50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:ARNIArno Therapeutics Inc (CE)
03/01/201715:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
03/01/201715:27Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:ARNIArno Therapeutics Inc (CE)
18/11/201615:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ARNIArno Therapeutics Inc (CE)
14/11/201615:14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARNIArno Therapeutics Inc (CE)
04/11/201615:42Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ARNIArno Therapeutics Inc (CE)
04/11/201605:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARNIArno Therapeutics Inc (CE)
12/10/201614:05Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ARNIArno Therapeutics Inc (CE)
08/09/201615:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:ARNIArno Therapeutics Inc (CE)
30/08/201614:10Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:ARNIArno Therapeutics Inc (CE)
16/08/201608:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARNIArno Therapeutics Inc (CE)
16/08/201607:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ARNIArno Therapeutics Inc (CE)
15/04/201609:53Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ARNIArno Therapeutics Inc (CE)
01/04/201614:40Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARNIArno Therapeutics Inc (CE)
30/03/201615:06Edgar (US Regulatory)Annual Report (10-k)USOTC:ARNIArno Therapeutics Inc (CE)
24/03/201615:43Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:ARNIArno Therapeutics Inc (CE)
17/02/201515:30Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:ARNIArno Therapeutics Inc (CE)
17/02/201515:05Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ARNIArno Therapeutics Inc (CE)
18/07/201415:30GlobeNewswire Inc.Arno Therapeutics, Inc. Appoints Alexander Zukiwski, M.D. as Interim Chief Executive Officer and Mr. Lawrence Kenyon as Chief...USOTC:ARNIArno Therapeutics Inc (CE)
29/05/201415:30GlobeNewswire Inc.Arno Therapeutics to Present at the Jefferies 2014 Global Healthcare ConferenceUSOTC:ARNIArno Therapeutics Inc (CE)
15/05/201415:40GlobeNewswire Inc.Arno Therapeutics Reports First Quarter 2014 Financial and Business UpdateUSOTC:ARNIArno Therapeutics Inc (CE)
14/05/201416:00GlobeNewswire Inc.Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men's and Women's Cancers at 2014 ASCO Annual Meet...USOTC:ARNIArno Therapeutics Inc (CE)
05/05/201407:30GlobeNewswire Inc.Arno Therapeutics Announces Clinical Abstracts Accepted at 2014 ASCO Annual MeetingUSOTC:ARNIArno Therapeutics Inc (CE)
07/04/201409:42GlobeNewswire Inc.Arno Therapeutics Enrolls First Patient in a Phase I/II Trial Evaluating Onapristone in Men with Advanced Castration-Resistan...USOTC:ARNIArno Therapeutics Inc (CE)
01/04/201408:10GlobeNewswire Inc.Arno Therapeutics Reports 2013 Financial Results and Provides Update on Strategic and Operational MilestonesUSOTC:ARNIArno Therapeutics Inc (CE)
 Showing the most relevant articles for your search:USOTC:ARNI

Su Consulta Reciente

COIN
NTBKUSD
USOTC
BMCS
BioTech Medics (PK)
POLO
RFDUSDT
REFUND
BIT
P1WW40
NLBNPIT1WW40 20240920 15
BIT
S30591
Societe Generale Effekten
EU
APHSF
LAssistance 23.09.2043
USOTC
EJVDF
EJF Investments (PK)
BOV
BPAC5M
BTG PACTUAL PNA
NASDAQ
HOVR
New Horizon Aircraft
LVCN
IDHETH
indaHash
USOTC
BECTY
Bechtle (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados